| scholarly article | Q13442814 |
| P356 | DOI | 10.1093/TOXSCI/KFQ346 |
| P953 | full work available at URL | https://academic.oup.com/toxsci/article-pdf/120/suppl_1/S238/4586743/kfq346.pdf |
| P698 | PubMed publication ID | 21097995 |
| P5875 | ResearchGate publication ID | 49629167 |
| P50 | author | David A Basketter | Q90845405 |
| P2093 | author name string | G. Frank Gerberick | |
| Ian Kimber | |||
| Cindy A. Ryan | |||
| Rebecca J. Dearman | |||
| P2860 | cites work | Association between HLA genes and susceptibility to toluene diisocyanate-induced asthma | Q58877324 |
| GM-CSF and TNF-α cooperate in the generation of dendritic Langerhans cells | Q59067424 | ||
| Asthma death after spraying polyurethane truck bedliner | Q23912001 | ||
| Skin exposure to isocyanates: reasons for concern | Q23912082 | ||
| The determination of draining lymph node cell cytokine mRNA levels in BALB/c mice following dermal sodium lauryl sulfate, dinitrofluorobenzene, and toluene diisocyanate exposure | Q23922268 | ||
| IL-17 and Th17 Cells | Q27860566 | ||
| Dendritic cells and the control of immunity | Q27860918 | ||
| Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha | Q28251443 | ||
| Variable effects of chemical allergens on serum IgE concentration in mice. Preliminary evaluation of a novel approach to the identification of respiratory sensitizers | Q28317497 | ||
| Divergent immune responses to respiratory and contact chemical allergens: antibody elicited by phthalic anhydride and oxazolone | Q28319602 | ||
| Differential ability of occupational chemical contact and respiratory allergens to cause immediate and delayed dermal hypersensitivity reactions in mice | Q28320075 | ||
| Inhalation exposure of mice to trimellitic anhydride induces both IgG and IgE anti-hapten antibody | Q28333479 | ||
| The induction of respiratory allergy in guinea-pigs following intradermal injection of trimellitic anhydride: a comparison with the response to 2,4-dinitrochlorobenzene | Q28339691 | ||
| Human T lymphocyte priming in vitro by haptenated autologous dendritic cells | Q28343499 | ||
| Role of CD4(+) T helper 2-type cells in cutaneous inflammatory responses induced by fluorescein isothiocyanate | Q28345274 | ||
| Interleukin (IL)-18 induces Langerhans cell migration by a tumour necrosis factor-alpha- and IL-1beta-dependent mechanism | Q28362345 | ||
| Assessment of preferential T-helper 1 or T-helper 2 induction by low molecular weight compounds using the local lymph node assay in conjunction with RT-PCR and ELISA for interferon-gamma and interleukin-4 | Q28368388 | ||
| Direct, MHC-dependent presentation of the drug sulfamethoxazole to human alphabeta T cell clones | Q28379004 | ||
| Skin exposure and asthma: is there a connection? | Q28395994 | ||
| FOXP3+ regulatory T cells in the human immune system | Q29307487 | ||
| How regulatory T cells work | Q29614262 | ||
| Mechanisms of foxp3+ T regulatory cell-mediated suppression | Q29615842 | ||
| Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor | Q29619247 | ||
| Selective and site-specific mobilization of dermal dendritic cells and Langerhans cells by Th1- and Th2-polarizing adjuvants | Q30495004 | ||
| Contact allergenic potency: correlation of human and local lymph node assay data. | Q30659411 | ||
| ICCVAM evaluation of the murine local lymph node assay. Data analyses completed by the National Toxicology Program Interagency Center for the Evaluation of Alternative Toxicological Methods | Q30667390 | ||
| Advances in acid anhydride induced occupational asthma | Q30833055 | ||
| Temporal changes in cytokine gene expression profiles induced in mice by trimellitic anhydride | Q30869684 | ||
| Recent developments in diisocyanate asthma | Q31143737 | ||
| Methods for the prediction of low-molecular-weight occupational respiratory sensitizers | Q37100864 | ||
| Lung/skin connections in occupational lung disease | Q37100872 | ||
| Th17 and allergy. | Q37143738 | ||
| Identification of a dendritic cell receptor that couples sensing of necrosis to immunity | Q37164859 | ||
| In vitro human T cell sensitization to haptens by monocyte-derived dendritic cells | Q31462271 | ||
| Functional caspase-1 is required for Langerhans cell migration and optimal contact sensitization in mice | Q32133034 | ||
| Assessment of the U937 cell line for the detection of contact allergens | Q33274283 | ||
| Investigating protein haptenation mechanisms of skin sensitisers using human serum albumin as a model protein | Q33275072 | ||
| Updating the skin sensitization in vitro data assessment paradigm in 2009. | Q33457249 | ||
| Comparative DNA microarray analysis of human monocyte derived dendritic cells and MUTZ-3 cells exposed to the moderate skin sensitizer cinnamaldehyde | Q33467255 | ||
| Activation and expansion of hapten- and protein-specific T helper cells from nonsensitized mice | Q33636274 | ||
| Immune responses to contact allergens: novel approaches to hazard evaluation | Q33686160 | ||
| Thresholds in contact sensitization: theoretical and practical considerations | Q33717202 | ||
| Local lymph node assay: use in hazard and risk assessment | Q33747789 | ||
| Important issues in occupational asthma | Q33802221 | ||
| Local lymph node assay: validation assessment for regulatory purposes | Q33843377 | ||
| Contact allergy, irritancy and 'danger'. | Q33869161 | ||
| Cytokines and chemokines in the initiation and regulation of epidermal Langerhans cell mobilization | Q33874509 | ||
| Langerhans cell migration | Q34049853 | ||
| Skin sensitization testing in potency and risk assessment | Q34131473 | ||
| Approaches for the development of cell-based in vitro methods for contact sensitization | Q34190391 | ||
| Cytokine fingerprinting and hazard assessment of chemical respiratory allergy | Q34208518 | ||
| Dendritic cell lineage, plasticity and cross-regulation | Q34295294 | ||
| Alternative approaches to the identification and characterization of chemical allergens | Q34376232 | ||
| Mechanisms underlying lineage commitment and plasticity of helper CD4+ T cells | Q34383385 | ||
| ICCVAM evaluation of the murine local lymph node assay. The ICCVAM review process | Q34469249 | ||
| ICCVAM evaluation of the murine local lymph node assay. Conclusions and recommendations of an independent scientific peer review panel | Q34469255 | ||
| Components of the ligand for a Ni++ reactive human T cell clone | Q34531789 | ||
| The regulation of Foxp3 expression in regulatory CD4(+)CD25(+)T cells: multiple pathways on the road | Q34575923 | ||
| Allergic contact dermatitis: the cellular effectors | Q34579690 | ||
| Local lymph node assay - validation, conduct and use in practice | Q34602747 | ||
| Skin sensitizers induce antioxidant response element dependent genes: application to the in vitro testing of the sensitization potential of chemicals | Q34700532 | ||
| Chemokines and the homing of dendritic cells to the T cell areas of lymphoid organs | Q34756572 | ||
| Plasticity of CD4+ T cell lineage differentiation. | Q34982725 | ||
| Chemical allergy: considerations for the practical application of cytokine profiling | Q35058425 | ||
| The local lymph node assay: past, present and future | Q35064426 | ||
| Pathogenesis of occupational asthma. | Q35210447 | ||
| Epidermal Langerhans cell migration and sensitisation to chemical allergens | Q35219331 | ||
| Activity of human contact allergens in the murine local lymph node assay | Q46785301 | ||
| Identification of metal allergens in the local lymph node assay | Q46822779 | ||
| The local lymph node assay in practice: a current regulatory perspective | Q46880318 | ||
| The local lymph node assay: current position in the regulatory classification of skin sensitizing chemicals | Q46901969 | ||
| IL-18 is a key proximal mediator of contact hypersensitivity and allergen-induced Langerhans cell migration in murine epidermis | Q46913482 | ||
| A loose-fit coculture of activated keratinocytes and dendritic cell-related cells for prediction of sensitizing potential | Q46914128 | ||
| CD8+ T cells are effector cells of contact dermatitis to common skin allergens in mice. | Q46926239 | ||
| The reduced local lymph node assay: the impact of group size | Q47269872 | ||
| Airway morphology and function of rats following dermal sensitization and respiratory challenge with low molecular weight chemicals | Q47279998 | ||
| A tier approach for evaluating the respiratory allergenicity of low molecular weight chemicals | Q47420735 | ||
| Analysis of cytokine mRNA expression following repeated exposure of mice to chemical contact and respiratory allergens | Q47762973 | ||
| The significance of specific IgG4 antibodies to methyltetrahydrophthalic anhydride in occupationally exposed subjects | Q47793592 | ||
| Cytokine production by CD4+ and CD8+ T cells in mice following primary exposure to chemical allergens: evidence for functional differentiation of T lymphocytes in vivo | Q47888394 | ||
| IL-1beta-induced Langerhans' cell migration and TNF-alpha production in human skin: regulation by lactoferrin | Q47969493 | ||
| A close-up view of migrating Langerhans cells in the skin. | Q49023130 | ||
| Gene expression studies in cultured dendritic cells: new indicators for the discrimination of skin sensitizers and irritants in vitro. | Q51567495 | ||
| Some active areas of DC research and their medical potential | Q51792965 | ||
| Reactivity profiling: covalent modification of single nucleophile peptides for skin sensitization risk assessment. | Q51818149 | ||
| An ATS/ERS report: 100 key questions and needs in occupational asthma. | Q53259397 | ||
| B220 analysis with the local lymph node assay: proposal for a more flexible prediction model. | Q53569356 | ||
| Inconsistencies between cytokine profiles, antibody responses, and respiratory hyperresponsiveness following dermal exposure to isocyanates. | Q53589788 | ||
| The local lymph node assay and skin sensitization: a cut-down screen to reduce animal requirements? | Q53598235 | ||
| Chemical respiratory allergy. Toxicological and occupational health issues. | Q53919536 | ||
| A chemical dataset for evaluation of alternative approaches to skin-sensitization testing. | Q54077835 | ||
| Ueber die Nerven der menschlichen Haut | Q54268491 | ||
| Improved methods for the generation of dendritic cells from nonproliferating progenitors in human blood. | Q54451826 | ||
| How many mechanisms do regulatory T cells need? | Q54568607 | ||
| Topical application versus intranasal instillation: a qualitative comparison of the effect of the route of sensitization on trimellitic anhydride-induced allergic rhinitis in A/J mice. | Q54609038 | ||
| An innate sense of danger | Q56672999 | ||
| Langerin Expressing Cells Promote Skin Immune Responses under Defined Conditions | Q57275421 | ||
| The cellular and molecular basis for divergent allergic responses to chemicals | Q35369902 | ||
| Dendritic cells and cutaneous immune responses to chemical allergens | Q35623456 | ||
| Dendritic cells and skin sensitisation hazard assessment | Q35646125 | ||
| Immunologic influences on allergy and the TH1/TH2 balance | Q35646852 | ||
| Smoking and occupational allergy in workers in a platinum refinery | Q35717590 | ||
| T lymphocyte-mediated immune responses to chemical haptens and metal ions: implications for allergic and autoimmune disease | Q35792757 | ||
| The murine local lymph node assay: a commentary on collaborative studies and new directions | Q35959443 | ||
| Dendritic cell-mediated T cell polarization | Q35988802 | ||
| Different faces of regulatory DCs in homeostasis and immunity | Q36061016 | ||
| What makes a chemical a respiratory sensitizer? | Q36069921 | ||
| Experimental approaches to evaluate respiratory allergy in animal models | Q36091573 | ||
| Interactions of contact allergens with dendritic cells: opportunities and challenges for the development of novel approaches to hazard assessment | Q36193152 | ||
| Cytokines and Langerhans cell mobilisation in mouse and man. | Q36254014 | ||
| Inducible ablation of mouse Langerhans cells diminishes but fails to abrogate contact hypersensitivity | Q36321301 | ||
| Assessing the potential to induce respiratory hypersensitivity | Q36337152 | ||
| Resting and sensitized T lymphocytes exhibit distinct stimulatory (antigen-presenting cell) requirements for growth and lymphokine release | Q36349639 | ||
| Proliferating dendritic cell progenitors in human blood | Q36363279 | ||
| Langerhans cells--revisiting the paradigm using genetically engineered mice | Q36386939 | ||
| Heterogeneity and plasticity of T helper cells | Q36388771 | ||
| Epidermal Langerhans cells--changing views on their function in vivo. | Q36530941 | ||
| Diversity of cytokine synthesis and function of mouse CD4+ T cells | Q36539209 | ||
| Heat shock proteins HSP27 and HSP70 are present in the skin and are important mediators of allergic contact hypersensitivity | Q36613524 | ||
| The evolving function of Langerhans cells in adaptive skin immunity | Q36627481 | ||
| Clinical and immunologic evaluation of trimellitic anhydride-and phthalic anhydride-exposed workers using a questionnaire with comparative analysis of enzyme-linked immunosorbent and radioimmunoassay studies | Q36645066 | ||
| Dermal dendritic cells, and not Langerhans cells, play an essential role in inducing an immune response | Q36690927 | ||
| Screening petrochemicals for contact hypersensitivity potential: a comparison of the murine local lymph node assay with guinea pig and human test data | Q36729082 | ||
| Early molecular events in the induction phase of contact sensitivity | Q36837916 | ||
| Toll-like receptor and IL-12 signaling control susceptibility to contact hypersensitivity | Q36853445 | ||
| The local lymph node assay and the assessment of relative potency: status of validation | Q36879552 | ||
| DC ablation in mice: promises, pitfalls, and challenges | Q36983300 | ||
| Respiratory sensitization and allergy: current research approaches and needs | Q37006799 | ||
| Dendritic cells and T cells in the regulation of cutaneous immunity | Q37045247 | ||
| Chemical respiratory allergy and occupational asthma: what are the key areas of uncertainty? | Q37094750 | ||
| Concentration-dependent immunologic response to toluene diisocyanate (TDI) following inhalation exposure | Q46569763 | ||
| Workshop overview. Identification of respiratory allergens | Q46611052 | ||
| Expression analysis of immune-related genes in CD34(+) progenitor-derived dendritic cells after exposure to the chemical contact allergen DNCB. | Q46672295 | ||
| Comparison of the skin sensitizing potential of unsaturated compounds as assessed by the murine local lymph node assay (LLNA) and the guinea pig maximization test (GPMT). | Q46699801 | ||
| Anti-inflammatory and immune-regulatory mechanisms prevent contact hypersensitivity to Arnica montana L. | Q46701571 | ||
| Skin sensitization: reaction mechanistic applicability domains for structure-activity relationships | Q46707312 | ||
| Results with OECD recommended positive control sensitizers in the maximization, Buehler and local lymph node assays | Q40881751 | ||
| Origin, maturation and antigen presenting function of dendritic cells. | Q40906220 | ||
| The role of the skin in the development of chemical respiratory hypersensitivity | Q41035765 | ||
| Evaluation of the capacity of dendritic cells derived from cord blood CD34+ precursors to present haptens to unsensitized autologous T cells in vitro | Q41051642 | ||
| The expanding universe of T-cell subsets: Th1, Th2 and more. | Q41120396 | ||
| The local lymph node assay: status of validation | Q41333570 | ||
| Acute ablation of Langerhans cells enhances skin immune responses | Q41906344 | ||
| Relationship between chemical structure and the occupational asthma hazard of low molecular weight organic compounds | Q41910929 | ||
| Patients with allergic contact dermatitis to nickel and nonallergic individuals display different nickel-specific T cell responses. Evidence for the presence of effector CD8+ and regulatory CD4+ T cells | Q42539151 | ||
| In vitro primary sensitization of hapten-specific T cells by cultured human epidermal Langerhans cells--a screening predictive assay for contact sensitizers | Q42555051 | ||
| An official ATS proceedings: asthma in the workplace: the Third Jack Pepys Workshop on Asthma in the Workplace: answered and unanswered questions | Q42630527 | ||
| Skin-draining lymph nodes contain dermis-derived CD103(-) dendritic cells that constitutively produce retinoic acid and induce Foxp3(+) regulatory T cells | Q42830424 | ||
| Loxoribine, a selective Toll-like receptor 7 agonist, induces maturation of human monocyte-derived dendritic cells and stimulates their Th-1- and Th-17-polarizing capability. | Q42917654 | ||
| Functional specializations of human epidermal Langerhans cells and CD14+ dermal dendritic cells | Q43120646 | ||
| Investigation of peptide reactivity of pro-hapten skin sensitizers using a peroxidase-peroxide oxidation system | Q43277469 | ||
| Characterization of p-phenylenediamine-albumin binding sites and T-cell responses to hapten-modified protein | Q43285197 | ||
| Validation of a non-invasive technique to assess immediate or delayed onset of airway hypersensitivity in guinea-pigs | Q43490445 | ||
| Development of non-radio isotopic endpoint of murine local lymph node assay based on 5-bromo-2'-deoxyuridine (BrdU) incorporation | Q43540930 | ||
| Allergen-induced changes in interleukin 1 beta (IL-1 beta) mRNA expression by human blood-derived dendritic cells: inter-individual differences and relevance for sensitization testing | Q43565720 | ||
| Exogenous topical lactoferrin inhibits allergen-induced Langerhans cell migration and cutaneous inflammation in humans | Q43572227 | ||
| Glutathione S-transferase genotypes and allergic responses to diisocyanate exposure | Q43686372 | ||
| Induced changes in total serum IgE concentration in the Brown Norway rat: potential for identification of chemical respiratory allergens | Q43864536 | ||
| Cytokine profiling for chemical sensitizers: application of the ribonuclease protection assay and effect of dose | Q43924948 | ||
| Respiratory hypersensitivity to trimellitic anhydride in Brown Norway rats: a comparison of endpoints | Q43938388 | ||
| N-Acetyltransferase genotypes as modifiers of diisocyanate exposure-associated asthma risk | Q43943535 | ||
| Application of a weight of evidence approach to assessing discordant sensitisation datasets: implications for REACH. | Q43969516 | ||
| Glutathione S-transferase GSTP1 is a susceptibility gene for occupational asthma induced by isocyanates | Q43982684 | ||
| Differential regulation of epidermal langerhans cell migration by interleukins (IL)-1alpha and IL-1beta during irritant- and allergen-induced cutaneous immune responses | Q44078559 | ||
| Use of a B cell marker (B220) to discriminate between allergens and irritants in the local lymph node assay | Q44085269 | ||
| Interleukins 5 and 13 characterize immune responses to respiratory sensitizing acid anhydrides | Q44159868 | ||
| Cytokine production induced by low-molecular-weight chemicals as a function of the stimulation index in a modified local lymph node assay: an approach to discriminate contact sensitizers from respiratory sensitizers | Q44189128 | ||
| Cytokine fingerprinting of chemical allergens: species comparisons and statistical analyses | Q44207543 | ||
| The murine local lymph node assay: results of an inter-laboratory trial | Q44254376 | ||
| Differential roles for CD4 and CD8 T cells after diisocyanate sensitization: genetic control of TH2-induced lung inflammation | Q44438856 | ||
| Toll-like receptor ligand activation of murine bone marrow-derived dendritic cells | Q44517145 | ||
| Methods for the identification of chemical respiratory allergens in rodents: comparisons of cytokine profiling with induced changes in serum IgE. | Q44528192 | ||
| Sensitisation of guinea pigs by inhalation exposure to low molecular weight chemicals | Q44583749 | ||
| Gene expression changes in peripheral blood-derived dendritic cells following exposure to a contact allergen | Q44862653 | ||
| A murine local lymph node assay for the identification of contact allergens. Assay development and results of an initial validation study | Q44933209 | ||
| Development of a peptide reactivity assay for screening contact allergens | Q44978791 | ||
| Selective haptenation of cellular or extracellular protein by chemical allergens: association with cytokine polarization | Q45273243 | ||
| Electrophilic reaction chemistry of low molecular weight respiratory sensitizers. | Q45926750 | ||
| Langerhans cell migration: not necessarily always at the center of the skin sensitization universe. | Q45929088 | ||
| Use of IL-18 production in a human keratinocyte cell line to discriminate contact sensitizers from irritants and low molecular weight respiratory allergens. | Q46034802 | ||
| Reconstruction of three-dimensional human skin model composed of dendritic cells, keratinocytes and fibroblasts utilizing a handy scaffold of collagen vitrigel membrane | Q46176346 | ||
| Dermal contact with toluene diisocyanate (TDI) produces respiratory tract hypersensitivity in guinea pigs | Q46189525 | ||
| Cytokine profiling of chemical allergens in mice: impact of mitogen on selectivity of response | Q46236599 | ||
| Synergistic effects of chemical insult and toll-like receptor ligands on dendritic cell activation | Q46321032 | ||
| The performance of the local lymph node assay with chemicals identified as contact allergens in the human maximization test | Q46321126 | ||
| Allergen-induced cytokine phenotypes in mice: role of CD4 and CD8 T cell populations | Q46442621 | ||
| Multivariate QSAR analysis of a skin sensitization database | Q46506019 | ||
| Identification of contact and respiratory sensitizers using flow cytometry | Q46515196 | ||
| Impact of cutaneous IL-10 on resident epidermal Langerhans' cells and the development of polarized immune responses | Q46561857 | ||
| From innate to adaptive immune responses in contact hypersensitivity | Q37205744 | ||
| Insights into Langerhans cell function from Langerhans cell ablation models | Q37268972 | ||
| The development and function of regulatory T cells | Q37274250 | ||
| The IL-17 cytokine family and their role in allergic inflammation | Q37285279 | ||
| Nine lives: plasticity among T helper cell subsets | Q37292800 | ||
| Dendritic cells: biology of the skin | Q37363179 | ||
| Progress on the development of human in vitro dendritic cell based assays for assessment of the sensitizing potential of a compound | Q37397784 | ||
| Skin immune surveillance by T cells--a new order? | Q37445293 | ||
| Molecular mechanism and function of CD40/CD40L engagement in the immune system. | Q37474929 | ||
| Nrf2 activation by sulforaphane restores the age-related decrease of T(H)1 immunity: role of dendritic cells | Q37500619 | ||
| Patterns of pathogenesis: discrimination of pathogenic and nonpathogenic microbes by the innate immune system | Q37555597 | ||
| Chemical allergens--what are the issues? | Q37568230 | ||
| The role of T helper subsets in autoimmunity and allergy | Q37580545 | ||
| Potency values from the local lymph node assay: application to classification, labelling and risk assessment | Q37592650 | ||
| The Nrf2-Keap1-ARE toxicity pathway as a cellular sensor for skin sensitizers--functional relevance and a hypothesis on innate reactions to skin sensitizers. | Q37600564 | ||
| Effector and regulatory mechanisms in allergic contact dermatitis. | Q37617470 | ||
| Non-animal sensitization testing: state-of-the-art | Q37697804 | ||
| Revisiting the tolerogenicity of epidermal Langerhans cells | Q37704952 | ||
| Langerhans cells: critical regulators of skin immunity? | Q37721150 | ||
| Assessment of preferential Th1 or Th2 induction by low-molecular-weight compounds using a reverse transcription-polymerase chain reaction method: comparison of two mouse strains, C57BL/6 and BALB/c | Q38491447 | ||
| Antigen-presenting cells in the induction of contact hypersensitivity in mice: evidence that Langerhans cells are sufficient but not required | Q38516917 | ||
| Immunotoxicologic evaluation of the respiratory system: animal models for immediate- and delayed-onset pulmonary hypersensitivity | Q39494843 | ||
| Prediction of the contact sensitizing potential of chemicals using analysis of gene expression changes in human THP-1 monocytes | Q39667090 | ||
| Keratinocyte gene expression profiles discriminate sensitizing and irritating compounds. | Q39690057 | ||
| Performance of a novel keratinocyte-based reporter cell line to screen skin sensitizers in vitro. | Q39724841 | ||
| Comparison of a novel CXCL12/CCL5 dependent migration assay with CXCL8 secretion and CD86 expression for distinguishing sensitizers from non-sensitizers using MUTZ-3 Langerhans cells | Q39781292 | ||
| Role of protein haptenation in triggering maturation events in the dendritic cell surrogate cell line THP-1. | Q39854399 | ||
| Expression of surface markers on the human monocytic leukaemia cell line, THP-1, as indicators for the sensitizing potential of chemicals. | Q39865611 | ||
| The Langerhans cell controversy: are they immunostimulatory or immunoregulatory cells of the skin immune system? | Q39882251 | ||
| HMOX1 and NQO1 genes are upregulated in response to contact sensitizers in dendritic cells and THP-1 cell line: role of the Keap1/Nrf2 pathway. | Q39912388 | ||
| Nothing is perfect, not even the local lymph node assay: a commentary and the implications for REACH. | Q40003682 | ||
| Utility and limitations of a peptide reactivity assay to predict fragrance allergens in vitro. | Q40211645 | ||
| A future approach to measuring relative skin sensitising potency: a proposal | Q40316400 | ||
| Development of an in vitro skin sensitization test using human cell lines; human Cell Line Activation Test (h-CLAT). II. An inter-laboratory study of the h-CLAT. | Q40342048 | ||
| The cytokine-dependent MUTZ-3 cell line as an in vitro model for the screening of contact sensitizers. | Q40394149 | ||
| Evaluation of the skin sensitizing potency of chemicals by using the existing methods and considerations of relevance for elicitation. | Q40447298 | ||
| Classification of contact allergens according to potency: proposals | Q40555466 | ||
| Respiratory allergy: hazard identification and risk assessment | Q40644918 | ||
| A new type of metal recognition by human T cells: contact residues for peptide-independent bridging of T cell receptor and major histocompatibility complex by nickel | Q40646680 | ||
| Evaluation of the skin sensitization potential of chemicals using expression of co-stimulatory molecules, CD54 and CD86, on the naive THP-1 cell line | Q40662190 | ||
| Evaluation of CD86 expression and MHC class II molecule internalization in THP-1 human monocyte cells as predictive endpoints for contact sensitizers. | Q40691251 | ||
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | S238-68 | |
| P577 | publication date | 2010-11-22 | |
| P1433 | published in | Toxicological Sciences | Q2446966 |
| P1476 | title | Chemical allergy: translating biology into hazard characterization | |
| P478 | volume | 120 Suppl 1 |
| Q37905022 | Allergic contact dermatitis: effect of age. |
| Q98469515 | Application of the dermal sensitization threshold concept to chemicals classified as high potency category for skin sensitization assessment of ingredients for consumer products |
| Q57095380 | Are skin sensitisation test methods relevant for proteins? |
| Q52768273 | Assessment of the risk of respiratory sensitization from fragrance allergens released by air fresheners. |
| Q38222548 | Assessment of the skin sensitising potency of the lower alkyl methacrylate esters |
| Q38666553 | Azodicarbonamide (ADCA): A reconsideration of classification as a respiratory sensitiser |
| Q89923809 | Azodicarbonamide (ADCA): A reconsideration of classification as a respiratory sensitiser |
| Q40269161 | Bayesian integrated testing strategy (ITS) for skin sensitization potency assessment: a decision support system for quantitative weight of evidence and adaptive testing strategy. |
| Q39152424 | Bayesian integrated testing strategy to assess skin sensitization potency: from theory to practice. |
| Q47954819 | Behaviour of chemical respiratory allergens in novel predictive methods for skin sensitisation |
| Q38731604 | Binary test battery with KeratinoSens™ and h-CLAT as part of a bottom-up approach for skin sensitization hazard prediction |
| Q38142312 | Chemical allergy in humans: fresh perspectives. |
| Q47973756 | Cleaning and asthma: A systematic review and approach for effective safety assessment. |
| Q38041278 | Danger, intracellular signaling, and the orchestration of dendritic cell function in skin sensitization |
| Q38016220 | Dendritic cells and the assessment in vitro of skin sensitizing potential |
| Q47264850 | Determination of Protein Haptenation by Chemical Sensitisers within the Complexity of the Human Skin Proteome. |
| Q87984972 | Development of an In Vitro Method to Estimate the Sensitization Induction Level of Contact Allergens |
| Q38233627 | Diisocyanates, occupational asthma and IgE antibody: implications for hazard characterization |
| Q34572681 | Effect of mouse strain in a model of chemical-induced respiratory allergy |
| Q38724356 | Evaluation of in vitro assays for the assessment of the skin sensitization hazard of functional polysiloxanes and silanes |
| Q92572874 | Fragrance inhalation and adverse health effects: The question of causation |
| Q38598344 | Fragrance sensitisers: Is inhalation an allergy risk? |
| Q43456803 | Immunology of contact allergy |
| Q38026914 | Immunoregulation of skin sensitization and regulatory T cells |
| Q47877604 | In vitro detection of chemical allergens: an optimized assay using mouse bone marrow-derived dendritic cells |
| Q28393171 | In vitro methods for hazard assessment of industrial chemicals - opportunities and challenges |
| Q28384162 | Integrated decision strategies for skin sensitization hazard |
| Q27687785 | Mechanisms of chemical-induced innate immunity in allergic contact dermatitis |
| Q55345001 | Nature and kinetics of redox imbalance triggered by respiratory and skin chemical sensitizers on the human monocytic cell line THP-1. |
| Q50104593 | Non-animal methods to predict skin sensitization (II): an assessment of defined approaches *. |
| Q38019451 | Non-animal test methods for predicting skin sensitization potentials |
| Q51585934 | Optimised testing strategies for skin sensitization--the LLNA and beyond. |
| Q38788628 | Phospholipidomic Profile Variation on THP-1 Cells Exposed to Skin or Respiratory Sensitizers and Respiratory Irritant |
| Q28386501 | Predicting chemically-induced skin reactions. Part I: QSAR models of skin sensitization and their application to identify potentially hazardous compounds |
| Q30863703 | Predicting skin sensitizer potency based on in vitro data from KeratinoSens and kinetic peptide binding: global versus domain-based assessment |
| Q38721990 | Prediction of skin sensitization potency using machine learning approaches |
| Q92906152 | Proposal of GHS sub-categorization criteria for LLNA: BrdU-ELISA (OECD TG442B) |
| Q38551043 | Reporter cell lines for skin sensitization testing. |
| Q47741693 | Respiratory sensitization: toxicological point of view on the available assays |
| Q23912974 | Setting occupational exposure limits for chemical allergens-understanding the challenges |
| Q90381962 | Skin Doctor: Machine Learning Models for Skin Sensitization Prediction that Provide Estimates and Indicators of Prediction Reliability |
| Q38746275 | State of the art in non-animal approaches for skin sensitization testing: from individual test methods towards testing strategies |
| Q30918757 | Test battery with the human cell line activation test, direct peptide reactivity assay and DEREK based on a 139 chemical data set for predicting skin sensitizing potential and potency of chemicals |
| Q102056849 | The activity of methacrylate esters in skin sensitisation test methods II. A review of complementary and additional analyses |
| Q92073888 | The activity of methacrylate esters in skin sensitisation test methods: A review |
| Q51739072 | The future trajectory of adverse outcome pathways: a commentary. |
| Q38345368 | The lymphocyte transformation test in allergic contact dermatitis: New opportunities |
| Q90984715 | The use of Genomic Allergen Rapid Detection (GARD) assays to predict the respiratory and skin sensitising potential of e-liquids |
| Q39431484 | Understanding chemical allergen potency: role of NLRP12 and Blimp-1 in the induction of IL-18 in human keratinocytes |
| Q92106864 | Validation of the GARD™skin Assay for Assessment of Chemical Skin Sensitizers: Ring Trial Results of Predictive Performance and Reproducibility |
Search more.